STAT3 and neoplasm: This combination not only reduces cell proliferation, but also hinders metastasis by downregulating key proteins, such as vimentin and MMP9, while affecting signaling pathways, such as Akt and STAT3, to enhance tumor inhibition (Chen et al., 2024).